Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.

Nikolsky, Eugenia

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. [electronic resource] - Journal of the American College of Cardiology Aug 2004 - 547-53 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0735-1097

10.1016/j.jacc.2004.03.080 doi


Abciximab
Aged
Anemia--complications
Angioplasty, Balloon, Coronary--adverse effects
Antibodies, Monoclonal--therapeutic use
Blood Component Transfusion--statistics & numerical data
Female
Hematocrit
Hemorrhage--etiology
Hospital Mortality
Humans
Immunoglobulin Fab Fragments--therapeutic use
Incidence
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction--complications
Platelet Aggregation Inhibitors--therapeutic use
Predictive Value of Tests
Prognosis
Randomized Controlled Trials as Topic
Stents--adverse effects
Stroke--etiology
Survival Analysis
Treatment Outcome